Replies to post #8830 on GTC Biotherapeutics (fka GTCB)

[masterlongevity]

rituxan is on patent until 2017

[rustyboy]

It is worth noting that many moons ago GTC had programs with Centocor (now JNJ) and Abbott to make Remicade and Humira respectivly, both of which progressed to having animals which successfully produced the drugs.

[Lewis R Goudy]

Speaking of Erbitux,
DARMSTADT, Germany, Jan. 05, 2009 – A study published today in the Journal of Clinical Oncology demonstrates that the addition of Erbitux® (cetuximab) to standard oxaliplatin-based chemotherapy (FOLFOX-4) in previously untreated metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors results in significantly higher efficacy than chemotherapy alone. The OPUSa study demonstrated a remarkably high response rate (RR) of 61%, clearly exceeding that seen in patients treated with chemotherapy alone (RR 37%, p=0.011).

http://pharmalive.com/news/index.cfm?articleID=595317&categoryid=48